GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+5.35%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$110M
AUM Growth
+$110M
(+14%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
12.66%
Top 10 Holdings %
Top 10 Hldgs %
46.11%
Holding
87
New
22
Increased
11
Reduced
11
Closed
30
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$6.69M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.17M |
| 3 |
Cooper Companies
COO
|
$5.42M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$5.24M |
| 5 |
Boston Scientific
BSX
|
$5.11M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$4.21M |
| 2 |
Bristol-Myers Squibb
BMY
|
$4.16M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$3.38M |
| 4 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$3.31M |
| 5 |
Arrowhead Research
ARWR
|
$3.04M |
Sector Composition
| 1 | Healthcare | 76.92% |
| 2 | Technology | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $6.69M | 4.72% | +30,000 | New | +$6.69M |
|
|
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
| $6.17M | 4.35% | +80,000 | New | +$6.17M |
|
|
3
Cooper Companies
COO
$13.4B
| $5.42M | 3.82% | +40,000 | New | +$5.42M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $5.24M | 3.7% | +100,000 | New | +$5.24M |
|
|
5
Boston Scientific
BSX
$156B
| $5.11M | 3.6% | +400,000 | New | +$5.11M |
|
6
Medtronic
MDT
$119B
| $4.78M | 3.37% | +75,000 | New | +$4.78M |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.74M | 3.34% | +75,000 | New | +$4.74M |
|
8
Community Health Systems
CYH
$387M
| $4.54M | 3.2% | 100,000 +20,000 | +25% | +$907K |
|
9
AtriCure
ATRC
$1.84B
| $4.14M | 2.92% | 225,000 +140,000 | +165% | +$2.57M |
|
10
Insmed
INSM
$28.8B
| $4M | 2.82% | 200,000 +65,000 | +48% | +$1.3M |
|
|
SPNC
11
DELISTED
Spectranetics Corp
SPNC
| $3.26M | 2.3% | 142,600 +92,600 | +185% | +$2.12M |
|
12
Bruker
BRKR
$5.16B
| $3.16M | 2.23% | 130,000 +40,000 | +44% | +$971K |
|
|
GEVA
13
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $3.14M | 2.22% | +30,000 | New | +$3.14M |
|
|
TRNX
14
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.81M | 1.98% | 120,000 -10,000 | -8% | -$234K |
|
|
COV
15
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $2.71M | 1.91% | +30,000 | New | +$2.71M |
|
|
ANAC
16
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.66M | 1.88% | 150,000 +130,000 | +650% | +$2.31M |
|
17
HCA Healthcare
HCA
$94.5B
| $2.54M | 1.79% | +45,000 | New | +$2.54M |
|
|
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.37M | 1.67% | 10,000 +2,000 | +25% | +$473K |
|
|
RNA
19
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $2.21M | 1.56% | +175,000 | New | +$2.21M |
|
20
Accuray
ARAY
$157M
| $2.2M | 1.55% | 250,000 -150,018 | -38% | -$1.32M |
|
21
Enanta Pharmaceuticals
ENTA
$180M
| $2.15M | 1.52% | 50,000 +15,000 | +43% | +$646K |
|
|
GWPH
22
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.15M | 1.51% | 20,000 -5,000 | -20% | -$537K |
|
23
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.12M | 1.49% | +7,500 | New | +$2.12M |
|
|
AMAG
24
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $2.07M | 1.46% | 100,000 -92,057 | -48% | -$1.91M |
|
25
Amicus Therapeutics
FOLD
$2.34B
| $2M | 1.41% | +600,000 | New | +$2M |
|